Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Crevoisier

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology Research|January 1, 1989
Influence of liver cirrhosis upon the pharmacokinetics of tenoxicamC Crevoisier, P Y Zaugg, P Heizmann, et al.
European Journal of Clinical Pharmacology|December 22, 1998
Lack of bioequivalence of a generic mefloquine tablet with the standard productE Weidekamm, G Rüsing, H Caplain, et al.
Journal of Clinical Pharmacology|March 1, 1989
Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjectsP J Pentikäinen, L Välisalmi, J J Himberg, et al.
Critical Care Medicine|August 1, 1992
Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patientsR Malacrida, M E Fritz, P M Suter, et al.
Clinical Pharmacology and Therapeutics|November 1, 1990
Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepamM Bührer, P O Maitre, C Crevoisier, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetics of midazolam in patients recovering from cardiac surgeryP O Maitre, B Funk, C Crevoisier, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Food increases the bioavailability of mefloquineC Crevoisier, J Handschin, J Barré, et al.
Arzneimittel-Forschung|December 1, 1987
Lack of influence of etretinate on the intestinal absorption of D-xylose and of phytomenadione (vitamin K1) as representatives of hydrophilic and lipophilic compoundsD Hartmann, C Crevoisier, U C Dubach, et al.
Therapeutic Drug Monitoring|January 1, 1988
Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratioP H Hinderling, D Hartmann, C Crevoisier, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 31, 1998
Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjectsU E Gasser, C Crevoisier, M Ouwerkerk, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology Research|January 1, 1989
Influence of liver cirrhosis upon the pharmacokinetics of tenoxicamC Crevoisier, P Y Zaugg, P Heizmann, et al.
European Journal of Clinical Pharmacology|December 22, 1998
Lack of bioequivalence of a generic mefloquine tablet with the standard productE Weidekamm, G Rüsing, H Caplain, et al.
Journal of Clinical Pharmacology|March 1, 1989
Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjectsP J Pentikäinen, L Välisalmi, J J Himberg, et al.
Critical Care Medicine|August 1, 1992
Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patientsR Malacrida, M E Fritz, P M Suter, et al.
Clinical Pharmacology and Therapeutics|November 1, 1990
Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepamM Bührer, P O Maitre, C Crevoisier, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetics of midazolam in patients recovering from cardiac surgeryP O Maitre, B Funk, C Crevoisier, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Food increases the bioavailability of mefloquineC Crevoisier, J Handschin, J Barré, et al.
Arzneimittel-Forschung|December 1, 1987
Lack of influence of etretinate on the intestinal absorption of D-xylose and of phytomenadione (vitamin K1) as representatives of hydrophilic and lipophilic compoundsD Hartmann, C Crevoisier, U C Dubach, et al.
Therapeutic Drug Monitoring|January 1, 1988
Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratioP H Hinderling, D Hartmann, C Crevoisier, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 31, 1998
Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjectsU E Gasser, C Crevoisier, M Ouwerkerk, et al.
Pageof 4